OPSENS REPORTS Q1 2017 RESULTS

FOCUSED EXECUTION LEADS TO RECORD QUARTERLY REVENUES

Quebec City, Quebec, January 26, 2017 – Opsens Inc. (“Opsens” or the "Company") (TSXV:OPS) (OTCQX:OPSSF) today reported its results for the first quarter ended November 30, 2016.

HIGHLIGHTS

·        Fractional Flow Reserve ("FFR") revenues were $2,743,000 compared with $893,000 in the same quarter last year, an increase of $1,850,000 or 207%;

·        Consolidated revenues for Q1 2017 amounted to $3,745,000 compared with $1,711,000 in Q1 2016, an increase of $2,034,000 or 119%.

EXECUTION OF THE GROWTH STRATEGY

Opsens’ sales networks demonstrate success quarter over quarter. FFR revenues for the first quarter of 2017 represent more than 50% of Opsens’ FFR revenues for the 12-month period ended August 31, 2016. "We are convinced that the distinctive features of the OptoWire, widely recognized by key opinion leaders in the interventional cardiology field, will allow us to capitalize on the fast-growing FFR market," said Louis Laflamme, President and Chief Executive Officer of Opsens.

"We are putting in place the necessary investment and infrastructure to become a major player in the industry. The improvements to our production processes over the past few months have enabled us to increase our competitiveness and our ability to start to meet the growing demand for our products," added Mr. Laflamme.

OPSENS CLOSES $15 MILLION FINANCING TO SUPPORT MARKETING EXPANSION OF FFR PRODUCTS

Following the financing that closed on December 8, 2016, Opsens’ cash position is now approximately $17 million. This financial position provides the Company the flexibility necessary to execute its plan including the expansion of commercialization of its FFR products.

FINANCIAL RESULTS - FIRST QUARTER ENDED NOVEMBER 30, 2016

Opsens' product sales were $3,745,000 for the three-month period ended November 30, 2016 compared with $1,711,000 for the same period a year earlier. This significant growth is explained by an increase of $1,850,000 in FFR revenues.

Gross margin increased to $1,191,000 for the quarter ended November 30, 2016 from $483,000 for the same period last year.

Net loss amounted to $2,541,000 for the three-month period ended November 30, 2016 compared with a net loss of $1,658,000 in the corresponding period last year. Opsens’ breakthrough into new markets has generated increased sales and marketing expenses, which explains the difference.